Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Lotte Keikes, Miriam Koopman, Martijn M. Stuiver, Valery E. P. P. Lemmens, Martijn G. H. van Oijen & Cornelis J. A. Punt. (2020) Practice variation on hospital level in the systemic treatment of metastatic colorectal cancer in The Netherlands: a population-based study. Acta Oncologica 59:4, pages 395-403.
Read now
Read now
X. G. L. V. Pouwels, S. M. E. Geurts, B. L. T. Ramaekers, F. Erdkamp, B. E. P. J. Vriens, K. N. A. Aaldering, A. J. van de Wouw, M. W. Dercksen, T. J. Smilde, N. A. J. B. Peters, J. M. van Riel, M. J. Pepels, J. Heijnen-Mommers, M. A. Joore, V. C. G. Tjan-Heijnen & M. de Boer. (2020) The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry. Acta Oncologica 59:1, pages 82-89.
Read now
Read now
Bengt Glimelius & Per Pfeiffer. (2018) Do we make progress in elderly patients with metastatic colorectal cancer?. Acta Oncologica 57:11, pages 1422-1426.
Read now
Read now
Tim A. Labeur, David W. G. Ten Cate, R. Bart Takkenberg, Hicham Azahaf, Martijn G. H. van Oijen, Otto M. van Delden, Robert A. de Man, Jeroen L. A. van Vugt, Jan N. M. IJzermans, Ferry A. L. M. Eskens & Heinz-Josef Klümpen. (2018) Are we SHARP enough? The importance of adequate patient selection in sorafenib treatment for hepatocellular carcinoma. Acta Oncologica 57:11, pages 1467-1474.
Read now
Read now
J. Dierks, M. P. Gaspersz, A. Belkouz, J. L. A. van Vugt, R. J. S. Coelen, J. W. B. de Groot, A. J. ten Tije, W. G. Meijer, J. F. M. Pruijt, T. van Voorthuizen, D. J. van Spronsen, M. Rentinck, D. ten Oever, J. M. Smit, H. M. Otten, T. M. van Gulik, J. W. Wilmink, B. Groot Koerkamp & H. Klümpen. (2018) Translating the ABC-02 trial into daily practice: outcome of palliative treatment in patients with unresectable biliary tract cancer treated with gemcitabine and cisplatin. Acta Oncologica 57:6, pages 807-812.
Read now
Read now
J. P. M. Burbach, S. A. Kurk, R. R. J. Coebergh van den Braak, V. K. Dik, A. M. May, G. A. Meijer, C. J. A. Punt, G. R. Vink, M. Los, N. Hoogerbrugge, P. C. Huijgens, J. N. M. Ijzermans, E. J. Kuipers, M. E. de Noo, J. P. Pennings, A. M. T. van der Velden, C. Verhoef, P. D. Siersema, M. G. H. van Oijen, H. M. Verkooijen & M. Koopman. (2016) Prospective Dutch colorectal cancer cohort: an infrastructure for long-term observational, prognostic, predictive and (randomized) intervention research. Acta Oncologica 55:11, pages 1273-1280.
Read now
Read now
Bengt Glimelius, Christoffer Johansen, Ludvig Paul Muren & Mef Nilbert. (2014) Acta Oncologica and a new generation of scientists in oncology. Acta Oncologica 53:7, pages 849-851.
Read now
Read now
Articles from other publishers (40)
Hiroki Ishihara, Yuki Nemoto, Kazutaka Nakamura, Hidekazu Tachibana, Takashi Ikeda, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Hiroaki Shimmura, Yasunobu Hashimoto, Tsunenori Kondo & Toshio Takagi. (2023) Comparison of Outcomes Between Therapeutic Combinations Based on Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitor Monotherapy for First-Line Therapy of Patients with Advanced Renal Cell Carcinoma Outside of Clinical Trials: A Real-World Retrospective Multi-Institutional Study. Targeted Oncology 18:2, pages 209-220.
Crossref
Crossref
Hiroki Ishihara, Yuki Nemoto, Kazutaka Nakamura, Hidekazu Tachibana, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Hiroaki Shimmura, Yasunobu Hashimoto, Kazunari Tanabe, Tsunenori Kondo & Toshio Takagi. (2022) Changes in Real-World Outcomes in Patients with Metastatic Renal Cell Carcinoma from the Molecular-Targeted Therapy Era to the Immune Checkpoint Inhibitor Era. Targeted Oncology 17:3, pages 307-319.
Crossref
Crossref
Hiroki Ishihara, Hidekazu Tachibana, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Toshio Takagi, Junpei Iizuka, Hideki Ishida, Tsunenori Kondo & Kazunari Tanabe. (2022) Prognostic Impact of Trial-Eligibility Criteria in Patients with Metastatic Renal Cell Carcinoma. Urologia Internationalis 106:4, pages 368-375.
Crossref
Crossref
Marije E. Hamaker, Grant Punnett, Janelle Yorke & Fabio Gomes. 2022. Frailty in Older Adults with Cancer. Frailty in Older Adults with Cancer
203
218
.
John-John B. Schnog, Michael J. Samson, Rijk O. B. Gans & Ashley J. Duits. (2021) An urgent call to raise the bar in oncology. British Journal of Cancer 125:11, pages 1477-1485.
Crossref
Crossref
Khava I. E. Ibragimova, Sandra M. E. Geurts, Sander Croes, Frans Erdkamp, Joan B. Heijns, Jolien Tol, Birgit E. P. J. Vriens, Kirsten N. A. Aaldering, Marcus W. Dercksen, Manon J. A. E. Pepels, Natascha A. J. B. Peters, Linda van de Winkel, Dominique J. P. Tilli, Ingeborg J. H. Vriens, Maaike de Boer & Vivianne C. G. Tjan-Heijnen. (2021) Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry. Breast Cancer Research and Treatment 188:2, pages 571-581.
Crossref
Crossref
Anne-Marie Bouvier, Valérie Jooste, Maria José Sanchez-Perez, Maria José Bento, Jessica Rocha Rodrigues, Rafael Marcos-Gragera, Maria Carmen Carmona-Garcia, Miguel Angel Luque-Fernandez, Pamela Minicozzi, Véronique Bouvier, Kaire Innos, Milena Sant, L. Van Eycken, K. Henau, T. Grozeva, Z. Valerianova, K. Innos, M. Mägi, V. Bouvier, G. Launoy, M. Robaszkiewicz, A.M. Bouvier, V. Jooste, V. Babaev, A. Katalinic, E.J. Ólafsdóttir, L. Tryggvadóttir, C. Amati, P. Baili, S. Bonfarnuzzo, C. Margutti, E. Meneghini, P. Minicozzi, G. Moretti, M. Sant, C. Cirilli, G. Carrozzi, E. Spata, R. Tumino, P. Giorgi Rossi, M. Vicentini, F. Stracci, F. Bianconi, P. Contiero, G. Tagliabue, W. Kycler, M. Oko, P. Macek, J. Smok-Kalwat, M. Bielska-Lasota, W. Kycler, M. Oko, M.J. Bento, J Rodrigues, A. Mayer-da-Silva, A. Miranda, M. Primic-Žakelj, K. Jarm, E. Almar, A. Mateos, J. Bidaurrazaga, M. de la Cruz, C. Alberich, A. Torrella-Ramos, J.M. Díaz García, AI Marcos-Navarro, C. Carmona-Garcia, R. Marcos-Gragera, M.A. Luque-Fernandez, M.J. Sánchez-Pérez, E. Ardanaz, M. Guevara, C. Bouchardy & E. Fournier. (2021) Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study. Digestive and Liver Disease 53:5, pages 639-645.
Crossref
Crossref
Patricia A. H. Hamers, Marloes A. G. Elferink, Rebecca K. Stellato, Cornelis J. A. Punt, Anne M. May, Miriam Koopman & Geraldine R. Vink. (2020) Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real‐life data. International Journal of Cancer 148:2, pages 296-306.
Crossref
Crossref
Natalia Kunst, Fernando Alarid-Escudero, Eline Aas, Veerle M.H. Coupé, Deborah Schrag & Karen M. Kuntz. (2020) Estimating Population-Based Recurrence Rates of Colorectal Cancer over Time in the United States. Cancer Epidemiology, Biomarkers & Prevention 29:12, pages 2710-2718.
Crossref
Crossref
Hans Wildiers & Nienke A de Glas. (2020) Anticancer drugs are not well tolerated in all older patients with cancer. The Lancet Healthy Longevity 1:1, pages e43-e47.
Crossref
Crossref
Arnoud J. Templeton, Christopher M. Booth & Ian F. Tannock. (2020) Informing Patients About Expected Outcomes: The Efficacy-Effectiveness Gap. Journal of Clinical Oncology 38:15, pages 1651-1654.
Crossref
Crossref
Marije E. Hamaker, Lieke H. van Huis-Tanja & Siri Rostoft. (2020) Optimizing the geriatrician's contribution to cancer care for older patients. Journal of Geriatric Oncology 11:3, pages 389-394.
Crossref
Crossref
Tim A. Labeur, Sarah Berhane, Julien Edeline, Jean‐Frederic Blanc, Dominik Bettinger, Tim Meyer, Jeroen L. A. Van Vugt, David W. G. Ten Cate, Robert A. De Man, Ferry A. L. M. Eskens, Alessandro Cucchetti, Laura J. Bonnett, Otto M. Van Delden, Heinz‐Josef Klümpen, R. Bart Takkenberg & Philip J. Johnson. (2019) Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib. Liver International 40:1, pages 215-228.
Crossref
Crossref
S. Karim, Y. Xu, S. Kong, O. Abdel-Rahman, M.L. Quan & W.Y. Cheung. (2019) Generalisability of Common Oncology Clinical Trial Eligibility Criteria in the Real World. Clinical Oncology 31:9, pages e160-e166.
Crossref
Crossref
Kristine Ø. Aasebø, Anca Dragomir, Magnus Sundström, Artur Mezheyeuski, Per‐Henrik Edqvist, Geir Egil Eide, Fredrik Ponten, Per Pfeiffer, Bengt Glimelius & Halfdan Sorbye. (2019)
Consequences of a high incidence of microsatellite instability and
BRAF‐
mutated tumors: A population‐based cohort of metastatic colorectal cancer patients
. Cancer Medicine 8:7, pages 3623-3635.
Crossref
Crossref
Rebecca M. Prince, Melanie Powis, Alona Zer, Eshetu G. Atenafu & Monika K. Krzyzanowska. (2019) Hospitalisations and emergency department visits in cancer patients receiving systemic therapy: Systematic review and meta-analysis. European Journal of Cancer Care 28:1, pages e12909.
Crossref
Crossref
M. E. Hamaker & N. A. de Glas. 2019. Management of Breast Cancer in Older Women. Management of Breast Cancer in Older Women
251
261
.
Yvonne Schuller, Marieke Biegstraaten, Carla E. M. Hollak, Heinz-Josef Klümpen, Christine C. Gispen-de Wied & Violeta Stoyanova-Beninska. (2018) Oncologic orphan drugs approved in the EU – do clinical trial data correspond with real-world effectiveness?. Orphanet Journal of Rare Diseases 13:1.
Crossref
Crossref
Wolfgang Knauf, Ali Aldaoud, Ulrich Hutzschenreuter, Martine Klausmann, Stephanie Dille, Natalie Wetzel, Martina Jänicke & Norbert Marschner. (2018) Survival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials—data from the prospective German Tumour Registry Lymphatic Neoplasms. Annals of Hematology 97:12, pages 2437-2445.
Crossref
Crossref
Nelleke P.M. Brouwer, Amanda C.R.K. Bos, Valery E.P.P. Lemmens, Pieter J. Tanis, Niek Hugen, Iris D. Nagtegaal, Johannes H.W. de Wilt & Rob H.A. Verhoeven. (2018) An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients. International Journal of Cancer 143:11, pages 2758-2766.
Crossref
Crossref
Stine Braendegaard Winther, Pia Österlund, Åke Berglund, Bengt Glimelius, Camilla Qvortrup, Halfdan Sorbye & Per Pfeiffer. (2017) Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9. BMC Cancer 17:1.
Crossref
Crossref
Marije E. Hamaker & Frederiek van den Bos. (2017) Evidence-based maatwerk voor ouderen met kankerEvidence based tailoring of cancer care for older patients. Tijdschrift voor Gerontologie en Geriatrie 48:6, pages 263-270.
Crossref
Crossref
Karlijn J.G. Schulkes, Esteban T.D. Souwer, Leontine J.R. van Elden, Henk Codrington, Simone van der Sar-van der Brugge, Jan-Willem J. Lammers, Johanneke E.A. Portielje, Frederiek van den Bos & Marije E. Hamaker. (2017) Prognostic Value of Geriatric 8 and Identification of Seniors at Risk for Hospitalized Patients Screening Tools for Patients With Lung Cancer. Clinical Lung Cancer 18:6, pages 660-666.e1.
Crossref
Crossref
Karlijn J. G. Schulkes, Carin A. M. Pouw, Elisabeth J. M. Driessen, Leontine J. R. van Elden, Frederiek van den Bos, Maryska L. G. Janssen-Heijnen, Jan-Willem J. Lammers & Marije E. Hamaker. (2017) Lung Cancer in the Oldest Old: A Nation-Wide Study in The Netherlands. Lung 195:5, pages 627-634.
Crossref
Crossref
. (2017) Benchmarking recent national practice in rectal cancer treatment with landmark randomized controlled trials. Colorectal Disease 19:6, pages O219-O231.
Crossref
Crossref
M.D. Franken, E.M. van Rooijen, A.M. May, H. Koffijberg, H. van Tinteren, L. Mol, A.J. ten Tije, G.J. Creemers, A.M.T. van der Velden, B.C. Tanis, C.A. Uyl-de Groot, C.J.A. Punt, M. Koopman & M.G.H. van Oijen. (2017) Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer. European Journal of Cancer 75, pages 204-212.
Crossref
Crossref
Norbert Marschner, Michael Staehler, Lothar Müller, Arnd Nusch, Johanna Harde, Michaela Koska, Martina Jänicke & Peter J. Goebell. (2017) Survival of Patients With Advanced or Metastatic Renal Cell Carcinoma in Routine Practice Differs From That in Clinical Trials—Analyses From the German Clinical RCC Registry. Clinical Genitourinary Cancer 15:2, pages e209-e215.
Crossref
Crossref
Karlijn J. G. Schulkes, Esteban T. D. Souwer, Marije E. Hamaker, Henk Codrington, Simone van der Sar-van der Brugge, Jan-Willem J. Lammers, Johanneke E. A. Portielje, Leontine J. R. van Elden & Frederiek van den Bos. (2017) The Effect of A Geriatric Assessment on Treatment Decisions for Patients with Lung Cancer. Lung 195:2, pages 225-231.
Crossref
Crossref
R.J.W. van Kampen, D.J.A. Lobbezoo, M. de Boer, M.W. Dercksen, A.C. Voogd, F. van den Berkmortel, T.J. Smilde, A.J. van de Wouw, F.P.J. Peters, J.M.G. van Riel, N.A.J.B. Peters, P.G.M. Peer, M.A. Joore & V.C.G. Tjan-Heijnen. (2017) A real-world study on implementation of bevacizumab in a cohort of HER2-negative metastatic breast cancer patients: A study of the Southeast Netherlands Breast Cancer Consortium. Cancer Treatment and Research Communications 13, pages 3-8.
Crossref
Crossref
Alice M. Couwenberg, Maarten J. P. Burbach, Anke B. Smits, Marco Van Vulpen, Wilhemina M. U. Van Grevenstein, Peter G. Noordzij & Helena M. Verkooijen. (2016) The impact of retractor SPONGE-assisted laparoscopic surgery on duration of hospital stay and postoperative complications in patients with colorectal cancer (SPONGE trial): study protocol for a randomized controlled trial. Trials 17:1.
Crossref
Crossref
Karlijn J.G. Schulkes, Cindy Nguyen, Frederiek van den Bos, Leontine J.R. van Elden & Marije E. Hamaker. (2016) Selection of Patients in Ongoing Clinical Trials on Lung Cancer. Lung 194:6, pages 967-974.
Crossref
Crossref
Jorine 't Lam-Boer, Lydia G. Van der Geest, Cees Verhoef, Marloes E. Elferink, Miriam Koopman & Johannes H. de Wilt. (2016) Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population-based propensity-score adjusted study in the Netherlands. International Journal of Cancer 139:9, pages 2082-2094.
Crossref
Crossref
Jannemarie A.M. de Ridder, Eric P. van der Stok, Leonie J. Mekenkamp, Bastiaan Wiering, Miriam Koopman, Cornelis J.A. Punt, Cornelis Verhoef & Johannes H. de Wilt. (2016) Management of liver metastases in colorectal cancer patients: A retrospective case-control study of systemic therapy versus liver resection. European Journal of Cancer 59, pages 13-21.
Crossref
Crossref
Bostjan Seruga, Arnoud J Templeton, Francisco Emilio Vera Badillo, Alberto Ocana, Eitan Amir & Ian F Tannock. (2016) Under-reporting of harm in clinical trials. The Lancet Oncology 17:5, pages e209-e219.
Crossref
Crossref
Tessa Kennedy-Martin, Sarah Curtis, Douglas Faries, Susan Robinson & Joseph Johnston. (2015) A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials 16:1.
Crossref
Crossref
Lydia G. M. van der Geest, Jorine’t Lam-Boer, Miriam Koopman, Cees Verhoef, Marloes A. G. Elferink & Johannes H. W. de Wilt. (2015) Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. Clinical & Experimental Metastasis 32:5, pages 457-465.
Crossref
Crossref
L. Mol, M. Koopman, P. B. Ottevanger & C. J. A. Punt. (2015) RE: Generalizability of Trial Results to Elderly Medicare Patients With Advanced Solid Tumors. JNCI Journal of the National Cancer Institute 107:6, pages djv104-djv104.
Crossref
Crossref
Thorvardur R. Halfdanarson & Joleen M. Hubbard. 2015. Modern Management of Cancer of the Rectum. Modern Management of Cancer of the Rectum
287
310
.
D.Y.C. Heng, T.K. Choueiri, B.I. Rini, J. Lee, T. Yuasa, S.K. Pal, S. Srinivas, G.A. Bjarnason, J.J. Knox, M. MacKenzie, U.N. Vaishampayan, M.H. Tan, S.Y. Rha, F. Donskov, N. Agarwal, C. Kollmannsberger, S. North & L.A. Wood. (2014) Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials. Annals of Oncology 25:1, pages 149-154.
Crossref
Crossref
H. Sorbye, M. Cvancarova, C. Qvortrup, P. Pfeiffer & B. Glimelius. (2013) Age-dependent improvement in median and long-term survival in unselected population-based Nordic registries of patients with synchronous metastatic colorectal cancer. Annals of Oncology 24:9, pages 2354-2360.
Crossref
Crossref